Molly Grammel > Goodwin > Boston, United States > Lawyer Profile
Goodwin Offices
100 NORTHERN AVENUE
BOSTON MA 02210
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Molly Grammel
Position
Partner
Career
Molly Grammel is a partner in Goodwin’s Intellectual Property Litigation practice and is a member of the firm’s Life Sciences Disputes group. She has extensive federal trial experience in cutting-edge technology IP litigation that spans a diverse set of industries, including biologic and biosimilar drugs and artificial intelligence and machine learning. Molly is a go-to partner for managing complex, high stakes matters, including numerous representations involving products with greater than $1 billion annual US sales. Molly specializes in providing clients with business-focused counseling regarding litigation strategy and developing and executing substantive legal theories through stand-up roles in court. She is a practiced trial advocate who has had significant responsibility for presenting evidence and argument in trials before juries and judges in federal district courts across the country.
Molly also has extensive experience representing clients in appeals to Federal Circuit Courts, and representing patent owners and petitioners in post-grant challenges before the Patent Trial and Appeal Board of the United States Patent and Trademark Office.
Education
JD, 2013
University of Pennsylvania Law School (magna cum laude, Levy Scholarship)
BA, 2010
University of California, Los Angeles (magna cum laude, Phi Beta Kappa, college honors program)
Lawyer Rankings
United States > Intellectual property > Patents: litigation (full coverage)
Goodwin regularly fields ‘highly talented and capable trial teams’ to manage and achieve victories in complex patent litigation. The team possesses significant expertise in competitor disputes related to high technology and excels in proceedings before the PTAB. The practice also has a strong reputation in the life sciences sector, regularly representing brand companies in Hatch-Waxman cases. Elaine Blais, based in Boston, is a first-chair trial lawyer who specializes in pharma and biotech patents. Blais jointly leads the team with the esteemed Brett Schuman, who is based in San Francisco and excels in patent infringement related to mobile phone and telecoms technology. Other notable practitioners in Boston include Douglas Kline, a ‘skilled trial advocate’ who leverages over thirty years of experience trying patent disputes, and Molly Grammel, a key attorney involved in the team’s recent victory for Breeze Smoke. Naomi Birbach, in New York, is highly regarded for her work in post-grant proceedings, such as inter partes reviews, before the PTAB. In Silicon Valley, Neel Chatterjee
is sought after for his high-tech patent expertise.
Lawyer Rankings
Top Tier Firm Rankings
- Industry focus > Cannabis
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Intellectual property > Patents: licensing
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Dispute resolution > E-discovery
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Intellectual property > Patents: litigation (full coverage)
- Real estate > Real estate
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- M&A/corporate and commercial > Shareholder activism
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- International trade and national security > CFIUS
- Finance > Commercial lending
- M&A/corporate and commercial > Corporate governance
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- International trade and national security > Customs, export controls and economic sanctions
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Intellectual property > Patents: litigation (International Trade Commission)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Healthcare > Service providers
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Real estate > Real estate finance
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Finance > Financial services regulation